z-logo
open-access-imgOpen Access
Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non‐Integrating Viral Reprogramming Vector
Author(s) -
Sharma Arun,
Mücke Michael,
Seidman Christine E.
Publication year - 2018
Publication title -
current protocols in molecular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.533
H-Index - 42
eISSN - 1934-3647
pISSN - 1934-3639
DOI - 10.1002/cpmb.58
Subject(s) - reprogramming , induced pluripotent stem cell , peripheral blood mononuclear cell , sendai virus , biology , microbiology and biotechnology , viral vector , virology , computational biology , immunology , cell , virus , embryonic stem cell , genetics , in vitro , recombinant dna , gene
We describe a method to transform blood lymphocytes into human‐induced pluripotent stem cells by delivering four transcription factors with a non‐integrative virus. Using human peripheral blood mononuclear cells (PBMCs) as the source cell type for hiPSC reprogramming is advantageous since blood samples are rapidly and safely obtained from nearly‐all subjects. Reprogramming factors needed to make hiPSCs are introduced by infecting the PBMCs with non‐integrating Sendai virus vectors. Reprogrammed cells can subsequently be quickly expanded for downstream use. In this unit, we present current protocols for the isolation of PBMCs from a small sample of human blood and subsequent viral reprogramming and expansion of PBMCs into hiPSCs. © 2018 by John Wiley & Sons, Inc.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom